Celgene Acquires Abraxis BioScience to Broaden its Focus in Oncology
By Staff Editor
Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)
Published: 2 Sep-2010
DOI: 10.3833/pdr.v2010.i7.1357 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Celgene has signed a definitive merger agreement to acquire Abraxis BioScience for approximately US$2...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018